Alzheimer’s Drug Slows Cognitive Decline in Key Study

Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.

source https://www.nytimes.com/2022/09/27/business/alzheimers-drug-biogen-lecanemab.html